Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer

Jon Paul J. Voroney, Andrew Hope, Max R. Dahele, Thomas Purdy, Kevin N. Franks, Shannon Pearson, John B.C. Cho, Alex Sun, David G. Payne, Jean Pierre Bissonnette, Andrea Bezjak, Anthony M. Brade

Research output: Contribution to journalArticleAcademicpeer-review

75 Citations (Scopus)


Stereotactic body radiotherapy is an emerging treatment option for peripheral non-small cell lung cancer in medically inoperable patients. With high dose per fraction radiotherapy, late side effects are of possible concern. In our initial cohort of 42 patients treated with 54 to 60 Gy in three fractions, nine patients have rib fracture. The median dose to rib fracture sites was 46 to 50 Gy, depending on the method of dose calculation. We describe a typical case of poststereotactic radiotherapy rib fracture and present dosimetric analysis of patients with rib fracture.

Original languageEnglish
Pages (from-to)1035-1037
Number of pages3
JournalJournal of thoracic oncology
Issue number8
Publication statusPublished - Aug 2009


  • Non-small cell lung cancer
  • Rib fracture
  • Stereotactic body radiotherapy

Cite this